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Human breast carcinoma is a heterogeneous disease embracing diff erent pheno-
types with diff erent biological characteristics. Transcriptional profi ling has identifi ed 
fi ve breast cancer subtypes, of which the “basal epithelial” is the most aggressive, 
with a predilection for younger women, and correlates with poor prognosis.
Nestin, an intermediate fi lament protein, was originally identifi ed as a marker of 
neuroepithelial stem/progenitor cells in the brain. Recently, it was observed that nes-
tin is expressed in basal/myoepithelial cells of the normal mammary gland and was 
also later found in cancer stem like cells of many tumors. Some studies showed that 
nestin is robustly immunohistochemically expressed in basal epithelial and triple neg-
ative breast tumors and that its expression correlates with survival patients.
The increased expression of survivin, a member of the inhibitor-of-apoptosis (IAP) 
protein family, has been demonstrated to be associated with resistance to apoptosis. 
It has been reported that survivin and other IAP proteins cooperate to activate kinase 
cascades that control cell motility, thus stimulating tumour cell invasion and promot-
ing metastasis. This mechanism seems to play a central role in breast cancer progres-
sion and resistance to treatment.
The p53 protein represents the fi nal eff ector of the p14CDKN2AMDM2 pathway; 
in majority of human cancers, the TP53 gene is functionally inactivated. Lack or 
reduced expression levels of the p53 protein seem to be associated with a defective 
apoptotic response to genotoxic damage and, thus, to anticancer agents.
In this study, we evaluated the immunohistochemical expression of nestin in asso-
ciation with an anti-apoptotic protein, such as survivin, and a tumor suppressor fac-
tor, such as p53, and with Ki-67 proliferation index in bioptic samples of T4 breast 
tumors. The results will be discussed. 
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